P220025/S008: LimFlow System
FDA’s recorded scope: a manufacturing process change for the soft tip bond
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 3 FDA records to the applicant name LimFlow, Inc.. The collection includes 1 510(k) clearance. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 22, 2025 to Mar 18, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QWN appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P220025, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 6001 Oak Canyon, Suite 100, Irvine, CA, 92618, US. Recorded on K260188, decision dated Mar 18, 2026.
Valvulotome; Stent graft, infrapopliteal, venous arterialization.
FDA’s recorded scope: a manufacturing process change for the soft tip bond
FDA’s recorded scope: Approval for minor design modifications to the handle of the LimFlow Crossing and Extension Stent Grafts delivery system
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| LimFlow, Inc. | Class II | Feb 4, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LimFlow VectorK260188 | LimFlow, Inc. | 510(k) clearance | Mar 18, 2026 | FDA |
LimFlow SystemP220025/S008 | LimFlow, Inc. | PMA supplement | Jan 7, 2026 | FDA |
LimFlow SystemP220025/S007 | LimFlow, Inc. | PMA supplement | Oct 22, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.